Abnormal uterine bleeding. Other specified abnormal uterine and vaginal bleeding
Conditions
Interventions
3 puffs lidocaine spray cervically 3-5 min before biopsy.
Intervention 1: Control group: recieving 5 ml distilled water intra uterus before biopsy. Intervention 2: 3 puffs lidocaine spray cervically 5 min before biopsy then 5 ml intra uterine 2% lidocaine so
Placebo
Treatment - Drugs
Control group: recieving 5 ml distilled water intra uterus before biopsy.
3 puffs lidocaine spray cervically 5 min before biopsy then 5 ml intra uterine 2% lidocaine solution 3 minutes before biopsy.
5 ml intra uterine 2% lidocaine solution 3 minutes before biopsy.
Sponsors
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: diagnosis of AUB, no active uterine bleeding, willing to participate in the study, premenopausal women between 40-55 years, parity more than or equal to 1 Exclusion criteria: pregnancy, suspicious to PID, known cervical stenosis, known uncompensated cardio-pulmonary failure, active hepatic disease, allergy to lidocaine, no cooperation to pain assessment by VAS, chronic pelvic pain, nulliparity
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: during biopsy, immediately after biopsy, 15 min after biopsy. Method of measurement: visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Possible complications. Timepoint: during biopsy and after biopsy. Method of measurement: patient examination and questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElaheh Ouladsahebmadarek
Tabriz University of Medical Sciences
Outcome results
None listed